Patients with type 2 diabetes, treated with GLP-1 receptor agonists, show a decreased risk of being diagnosed with ...

A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, ...

Texas hairstylist Tim Bo Mack opened up to PEOPLE about his years-long struggle to lose weight. He finally found success ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Once known mainly for their role in weight management, GLP-1 receptor agonists, like semaglutide and tirzepatide, are now ...

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today released new data ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

CivicScience is a consumer analytics and advertising platform capturing over one million survey responses daily — turn ...